Nanalysis Scientific Corp. (CVE:NSCI – Get Free Report)’s share price hit a new 52-week low during trading on Wednesday . The company traded as low as C$0.11 and last traded at C$0.12, with a volume of 197239 shares traded. The stock had previously closed at C$0.12.
Nanalysis Scientific Price Performance
The company has a quick ratio of 1.10, a current ratio of 1.42 and a debt-to-equity ratio of 71.72. The company has a 50-day simple moving average of C$0.14 and a two-hundred day simple moving average of C$0.15. The stock has a market cap of C$16.61 million, a P/E ratio of -2.40 and a beta of -0.52.
About Nanalysis Scientific
Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies. It serves pharmaceutical, security, biotech, nutraceutical, chemical, food, materials, medical, and education industries.
Read More
- Five stocks we like better than Nanalysis Scientific
- Buyback Capacity Is Rising Across 3 Soaring and Sinking Stocks
- How to Invest in the Biggest European Defense Surge in Decades
- The Netflix-Lionsgate Rumor Exposed a Bigger Shift in Media M&A
- Credo Technologies Accelerates AI—Its Stock Price Will Follow
Receive News & Ratings for Nanalysis Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanalysis Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
